These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1064 related articles for article (PubMed ID: 3809195)

  • 1. Patterns of resistance to alkylating agents.
    Osieka R; Grunicke H; Brock N
    Prog Clin Biol Res; 1986; 223():129-41. PubMed ID: 3809195
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor activities of seventeen alkylating agents against human mammary carcinoma (MS-1) in nude mice.
    Inoue K; Fujimoto S; Ogawa M
    Nagoya J Med Sci; 1981 Mar; 43(3-4):89-100. PubMed ID: 7278943
    [No Abstract]   [Full Text] [Related]  

  • 3. Human malignant melanoma: preclinical and clinical drug evaluation.
    Osieka R
    Behring Inst Mitt; 1984 May; (74):353-67. PubMed ID: 6383327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increasing the tolerance of rats for alkylating preparations].
    Montsevichnote-Eringene EV
    Vopr Onkol; 1974; 20(4):66-70. PubMed ID: 4439818
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemosensitization by chlorpromazine (CPZ) and caffeine (C) in human melanoma xenografts sensitive or resistant to methyl-CCNU (semustine).
    Osieka R; Glatte P; Schmidt CG
    Strahlenther Onkol; 1989 Jul; 165(7):526-8. PubMed ID: 2749491
    [No Abstract]   [Full Text] [Related]  

  • 6. Properties of human melanoma cells resistant to 5-(3',3'-dimethyl-1-triazeno)imidazole-4-carboxamide and other methylating agents.
    Parsons PG; Smellie SG; Morrison LE; Hayward IP
    Cancer Res; 1982 Apr; 42(4):1454-61. PubMed ID: 7060019
    [No Abstract]   [Full Text] [Related]  

  • 7. Alkylating agents.
    Connors TA
    Cancer Chemother Biol Response Modif; 1991; 12():27-42. PubMed ID: 1931447
    [No Abstract]   [Full Text] [Related]  

  • 8. In-transit melanoma: the role of alkylating-agent resistance in regional therapy.
    Grubbs EG; Abdel-Wahab O; Cheng TY; Abdel-Wahab Z; Peterson B; Pruitt SK; Colvin OM; Friedman HS; Tyler DS
    J Am Coll Surg; 2004 Sep; 199(3):419-27. PubMed ID: 15325612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified screening system to select new cytostatic drugs.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical reversal of drug resistance in ovarian cancer.
    Ozols RF; O'Dwyer PJ; Hamilton TC
    Gynecol Oncol; 1993 Oct; 51(1):90-6. PubMed ID: 8244181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between melanogenesis, proliferative activity and response to chemotherapy of human melanoma xenografts.
    Siracký J; Sparrow S; Jones M
    Neoplasma; 1984; 31(5):545-9. PubMed ID: 6504213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of cell kinetics in prediction of the response to cancer therapy.
    Tannock I; Frei E
    Natl Cancer Inst Monogr; 1971 Dec; 34():19-24. PubMed ID: 5140864
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy of malignant melanoma].
    Wagenknecht L
    Schweiz Med Wochenschr; 1973 Oct; 103(41):1426-8. PubMed ID: 4127413
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis, cytostatic activity and mechanism of action of N-glycosylhalomethylazoles. A new class of alkylating agents].
    Alonso G; Alonso R; Camarasa MJ; Contreras A; García López MT; de las Heras FG; Herranz R; Sánchez-Pérez RM
    Rev Esp Oncol; 1982; 29(4):603-7. PubMed ID: 6927609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
    Porter CW; Bernacki RJ; Miller J; Bergeron RJ
    Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on crocker sarcoma under the effect of alkylating agents. I. Morpho-topochemical studies of Golgi apparatus and glycogen in malignant cells of sarcoma 180 after treatment with the antitumour drug DL-sarcolysine.
    el-Fiky SM; Taha Y
    Acta Histochem; 1969; 34(1):174-9. PubMed ID: 4983081
    [No Abstract]   [Full Text] [Related]  

  • 17. Alkylating agents.
    Lind MJ; Thatcher N
    Curr Opin Oncol; 1989 Dec; 1(2):192-7. PubMed ID: 2489959
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of various chemotherapeutic agents on the synthesis and distribution of DNA in human strains of kidney and lung cancer, melanoma and Ewing's sarcoma transplanted to athymic mice].
    Revazova ES; Petrova AS; Iudicheva TV; Zubrikhina TN
    Biull Eksp Biol Med; 1981 Oct; 91(10):471-3. PubMed ID: 7317610
    [No Abstract]   [Full Text] [Related]  

  • 19. An outline of cancer chemotherapy.
    Connors TA
    Rev Roum Inframicrobiol; 1971; 8(3):135-51. PubMed ID: 5152643
    [No Abstract]   [Full Text] [Related]  

  • 20. Alkylating agents.
    Berger NA
    Cancer Chemother Biol Response Modif; 1993; 14():26-36. PubMed ID: 8312105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 54.